DOCSLIB.ORG

The T-Box Transcription Factor Eomesodermin Acts Upstream of Mesp1 to Specify Cardiac Mesoderm During Mouse Gastrulation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The T-Box Transcription Factor Eomesodermin Acts Upstream of Mesp1 to Specify Cardiac Mesoderm During Mouse Gastrulation LETTERS The T-box transcription factor Eomesodermin acts upstream of Mesp1 to specify cardiac mesoderm during mouse gastrulation Ita Costello1, Inga-Marie Pimeisl2, Sarah Dräger2, Elizabeth K. Bikoff1, Elizabeth J. Robertson1,3 and Sebastian J. Arnold2,3 Instructive programmes guiding cell-fate decisions in the region of the primitive streak (APS), in close proximity to the developing mouse embryo are controlled by a few so-termed cardiovascular progenitors10,11. master regulators. Genetic studies demonstrate that the T-box Mesoderm formation and patterning along the proximodistal axis transcription factor Eomesodermin (Eomes) is essential for of the primitive streak is known to be regulated by dose-dependent epithelial-to-mesenchymal transition, mesoderm migration and Nodal/Smad2/3 activities7. The highest level of Nodal/Smad2/3 specification of definitive endoderm during gastrulation1. Here signalling is required to specify APS derivatives, namely the definitive we report that Eomes expression within the primitive streak endoderm, node and notochord5,6,8. The transcription factor Smad4, marks the earliest cardiac mesoderm and promotes formation and its DNA-binding partner the forkhead transcription factor Foxh1, of cardiovascular progenitors by directly activating the bHLH also play essential roles in APS specification6,12,13. Furthermore, (basic-helix-loop-helix) transcription factor gene Mesp1 the T-box transcription factor Eomes acts cooperatively with upstream of the core cardiac transcriptional machinery2–4. In the Nodal/Smad2/3 pathway to promote delamination of nascent marked contrast to Eomes/Nodal signalling interactions that mesoderm and specification of APS fates1. cooperatively regulate anterior–posterior axis patterning and Eomes expression is initiated in the prospective posterior aspect allocation of the definitive endoderm cell lineage1,5–8, formation of the epiblast at embryonic day 5.75 (E5.75; ref. 14). During of cardiac progenitors requires only low levels of Nodal activity gastrulation expression is maintained in the distal primitive streak14,15, accomplished through a Foxh1/Smad4-independent encompassing the same region where cranial, cardiac and paraxial mechanism. Collectively, our experiments demonstrate that mesodermal subcell populations are generated10. Inactivation of Eomes governs discrete context-dependent transcriptional Eomes in the epiblast results in a severe block in EMT and arrests programmes that sequentially specify cardiac and definitive development at gastrulation1. To further characterize Eomes functional endoderm progenitors during gastrulation. contributions within the mesodermal cell lineages we generated an EomesCre reporter allele. Cre messenger RNA expression recapitulates Much has been learned about the coordinated activities of key endogenous expression (Supplementary Fig. S1a), enabling derivation regulatory networks of transcription factors and growth-factor of a fate map of Eomes-expressing cells in later-stage embryos (Fig. 1). signalling pathways governing cell-fate decisions during gastrulation9. EomesCre=C males were mated to females carrying the ROSA26 R Nascent mesoderm is induced as epiblast cells ingress through the reporter allele16 and the resulting embryos stained for LacZ activity primitive streak and undergo epithelial-to-mesenchymal transition (Fig. 1d,e and Supplementary Fig. S1b). Surprisingly, we found in (EMT). Distinct mesodermal subpopulations become allocated E8.5 and E9.5 EomesCre ; ROSA26 R embryos that LacZ-expressing according to the timing and order of these cell movements. Thus cells are mostly absent from the somites, intermediate and lateral extra-embryonic mesoderm arises from the posterior primitive plate mesoderm and largely restricted to the head mesenchyme, streak, whereas cardiac, paraxial and lateral plate precursors emerge cardiac mesoderm and vasculature (Fig. 1d,e). As expected1, the sequentially as the primitive streak elongates towards the distal definitive endoderm and gut tube exclusively consist of LacZ-marked tip of the embryo. Fate-mapping experiments demonstrate that EomesCre -positive descendants. At later stages endodermal but not definitive endoderm progenitors are specified in the most anterior mesodermal components of developing organs derived from the gut 1Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK. 2University Medical Centre, Renal Department, Centre for Clinical Research, Breisacher Strasse 66, 79106 Freiburg, Germany. 3Correspondence should be addressed to E.J.R. or S.J.A. (e-mail: [email protected] or [email protected]) Received 26 January 2011; accepted 23 June 2011; published online 7 August 2011; DOI: 10.1038/ncb2304 NATURE CELL BIOLOGY ADVANCE ONLINE PUBLICATION 1 © 2011 Macmillan Publishers Limited. All rights reserved. LETTERS a 15.2 kb b Wild type 15.2 kb Eomes RV H SE HRV locus (wild type) Targeted 8.0 kb Targeting construct PGK-neo TK Cre RV Targeted RV H H RV neo allele PGK- Cre c 8.0 kb Wild type 15.2 kb RV Reporter RV H Targeted H RV 8.0 kb allele Reporter Cre 6.2 kb 6.2 kb de Hm Hm He E8.5 He Hm Gt Gt He Gt E9.5 Eomes Cre × ROSA26R Eomes Cre × ROSA26R Figure 1 Fate mapping of Eomes Cre -expressing cells reveals selective the phosphoglycerate kinase–neomycin (PGK-neo) selection cassette and contributions to definitive endoderm and cardiovascular cell lineages. generate the reporter allele, as shown by Southern blot. (d,e) Fate-mapping (a) Targeting strategy used to generate the Eomes Cre reporter allele. Cre experiments demonstrate that descendants of Eomes Cre -expressing cells recombinase coding sequences were inserted into exon 1 of the Eomes contribute to the myocardium and endocardium of the heart (He), the locus. RV, EcoRV; H, HpaI; S, SphI; E, EagI; Cre, Cre recombinase; head mesenchyme (Hm), vasculature and the endoderm of the primary TK, thymidine kinase. (b) Embryonic stem cell clones were screened gut tube (Gt), but rarely colonize other mesoderm tissues formed from by Southern blot on EcoRV-digested DNA using a 30 probe (red line paraxial and lateral plate mesoderm. Sections were counterstained with in a) to detect wild-type and targeted alleles. (c) Correctly targeted eosin to highlight non-labelled cells. The black lines indicate the plane embryonic stem cells were transiently transfected with Cre to excise of section. tube are LacZ positive (Supplementary Fig. S1c). Eomes-expressing Brachyury, Fgf8 and Snail (ref. 1). However, in marked contrast, cells thus give rise to two discrete progenitor cell populations during expression of the early cardiac marker genes Myl7 (also known as gastrulation, namely the prospective cranial and cardiac mesoderm Mlc2a), Wnt2 and Nkx2.5 was absent (Fig. 2a). Moreover, we observe that emerge from the primitive streak at early stages, and APS severely reduced expression of early vascular marker genes such as derivatives giving rise to the definitive endoderm, node and notochord. Agtrl1, Rasgrp3 and Klhl6 (Fig. 2a). In marked contrast, EomesC cells are excluded from the majority To test whether loss of cardiac-gene expression reflects a cell- of mesodermal tissues derived from the paraxial and lateral plate autonomous Eomes requirement we examined the developmental mesoderm. These observations indicate that a discrete subpopulation potential of Eomes-null embryonic stem cells in the context of chimaeric of cells within the pregastrulation epiblast preferentially ingress and embryos. Eomes-null embryonic stem cells1 were injected into wild-type migrate anteriorly as a cohort to form the cardiac crescent and blastocysts carrying the ROSA26LacZ allele17 and the resulting embryos prospective head mesoderm. analysed by LacZ staining (Fig. 2b). As expected1, at E8.5 and E9.5 To directly examine whether Eomes function is required for Eomes-null cells efficiently contribute to the majority of mesodermal specification of cardiovascular progenitors, we analysed E7.5 embryos tissues but are entirely excluded from the forming gut tube. Notably, in carrying an epiblast-specific Eomes deletion (EomesCA=N ;Sox2.Cre; all cases examined (n D 10), the myocardium and endocardium of the ref. 1) by whole-mount in situ hybridization. Embryos lacking developing heart also exclusively consisted of wild-type LacZ-positive Eomes function strongly express mesodermal marker genes, including cells (Fig. 2c,d). Thus we conclude that Eomes plays an essential 2 NATURE CELL BIOLOGY ADVANCE ONLINE PUBLICATION © 2011 Macmillan Publishers Limited. All rights reserved. LETTERS a E7.5 E7.5 E7.5 E7.5 E7.5 E7.75 b c Hm Wild type Gt Gt Eomes –/– embryonic stem cells E7.5 E7.5 E7.5 E7.5 E7.5 E7.75 He Eomes mutant d ROSA26 LacZ blastocyst / wild type Hm E7.75 E7.75 E7.75 E9.5 E9.5 E8.5 Gt Wild type He Myl7 Wnt2 Nkx2.5 Agtrl1 Rasgrp3 Klhl6 Figure 2 Eomes functional loss disrupts specification of cardiovascular for generation of chimaeric embryos. Eomes-null embryonic stem progenitors. (a) Whole-mount in situ hybridization analysis of cells were introduced into wild-type ROSA26LacZ blastocysts. cardiac mesoderm (Myl7, Wnt2, Nkx2.5) and vascular (Agtrl1, (c,d) Histological sections of two independent LacZ -stained E9.5 Rasgrp3, Klhl6) markers in control and Eomes N=CA;Sox2.Cre-mutant chimaeric embryos were counterstained with eosin to identify embryos. Eomes mutants entirely lack expression of cardiac Eomes-mutant cell populations (pink). The myocardium and endocardium marker genes and show significantly reduced expression
Load more

Recommended publications
  • Regulation of Cardiac Progenitors by Combination of Mesp1 and ETS
    REGULATION OF CARDIAC PROGENITORS BY COMBINATION OF MESP1 AND ETS TRANSCRIPTION FACTORS A Dissertation by KUO-CHAN WENG Submitted to the Office of Graduate and Professional Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Chair of Committee, Fen Wang Co-Chair of Committee, Robert J. Schwartz Committee Members, James F. Martin Jiang Chang Head of Department, Fen Wang May 2014 Major Subject: Medical Science Copyright 2014 Kuo-Chan Weng ABSTRACT Heart disease remains the leading cause of death worldwide. By understanding the regulating networks during cardiac development we can exploit those networks to manipulate adult cells into cardiac progenitors and provide an alternative for repairing diseased hearts. Mesp1 is considered to have critical roles during cardiac development but the molecular mechanisms need to be further studied. The roles of ETS transcription factors have been primarily limited to hematopoietic differentiation and cancer progression. The ETS transcription factors are known to have proliferating roles and were hypothesized to also be involved in cardiac differentiation and may potentially be used for cell reprogramming. The first part of this study characterizes the expression pattern of Mesp1 protein in early mouse embryo from E6.5 to E9.5 and provides a full expression profile in differentiating embryoid bodies in vitro from the undifferentiated stage to Day10. Our work showed Mesp1 expresses in the posterior region of E6.5 embryo then starts migrating through the primitive streak toward anterior mesoderm and endoderm in E7.5. A Mesp1 linage tracing ES cell line was established, and it allowed us to trace the Mesp1 derived cell population.
    [Show full text]
  • MKL1 (C) Antibody, Rabbit Polyclonal
    Order: (888)-282-5810 (Phone) (818)-707-0392 (Fax) [email protected] Web: www.Abiocode.com MKL1 (C) Antibody, Rabbit Polyclonal Cat#: R2403-2 Lot#: Refer to vial Quantity: 100 ul Application: WB Predicted I Observed M.W.: 99 I 140 kDa Uniprot ID: Q969V6 Background: MKL/myocardin-like protein 1 (MKL1) is a transcriptional coactivator of serum response factor (SRF) with the potential to modulate SRF target genes. MKL1 suppresses TNF-induced cell death by inhibiting activation of caspases; its transcriptional activity is indispensable for the antiapoptotic function. MKL1 may up-regulate antiapoptotic molecules, which in turn inhibit caspase activation. Other Names: MKL/myocardin-like protein 1, Megakaryoblastic leukemia 1 protein, Megakaryocytic acute leukemia protein, Myocardin-related transcription factor A, MRTF-A, KIAA1438, MAL Source and Purity: Rabbit polyclonal antibodies were produced by immunizing animals with a GST-fusion protein containing the C-terminal region of human MKL1. Antibodies were purified by affinity purification using immunogen. Storage Buffer and Condition: Supplied in 1 x PBS (pH 7.4), 100 ug/ml BSA, 40% Glycerol, 0.01% NaN3. Store at -20 °C. Stable for 6 months from date of receipt. Species Specificity: Human Tested Applications: WB: 1:1,000-1:3,000 (detect endogenous protein*) *: The apparent protein size on WB may be different from the calculated M.W. due to modifications. For research use only. Not for therapeutic or diagnostic purposes. Abiocode, Inc., 29397 Agoura Rd., Ste 106, Agoura Hills, CA 91301 Order: (888)-282-5810 (Phone) (818)-707-0392 (Fax) [email protected] Web: www.Abiocode.com Product Data: kDa A B 250 150 100 75 50 37 Fig 1.
    [Show full text]
  • Detailed Review Paper on Retinoid Pathway Signalling
    1 1 Detailed Review Paper on Retinoid Pathway Signalling 2 December 2020 3 2 4 Foreword 5 1. Project 4.97 to develop a Detailed Review Paper (DRP) on the Retinoid System 6 was added to the Test Guidelines Programme work plan in 2015. The project was 7 originally proposed by Sweden and the European Commission later joined the project as 8 a co-lead. In 2019, the OECD Secretariat was added to coordinate input from expert 9 consultants. The initial objectives of the project were to: 10 draft a review of the biology of retinoid signalling pathway, 11 describe retinoid-mediated effects on various organ systems, 12 identify relevant retinoid in vitro and ex vivo assays that measure mechanistic 13 effects of chemicals for development, and 14 Identify in vivo endpoints that could be added to existing test guidelines to 15 identify chemical effects on retinoid pathway signalling. 16 2. This DRP is intended to expand the recommendations for the retinoid pathway 17 included in the OECD Detailed Review Paper on the State of the Science on Novel In 18 vitro and In vivo Screening and Testing Methods and Endpoints for Evaluating 19 Endocrine Disruptors (DRP No 178). The retinoid signalling pathway was one of seven 20 endocrine pathways considered to be susceptible to environmental endocrine disruption 21 and for which relevant endpoints could be measured in new or existing OECD Test 22 Guidelines for evaluating endocrine disruption. Due to the complexity of retinoid 23 signalling across multiple organ systems, this effort was foreseen as a multi-step process.
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Watsonjn2018.Pdf (1.780Mb)
    UNIVERSITY OF CENTRAL OKLAHOMA Edmond, Oklahoma Department of Biology Investigating Differential Gene Expression in vivo of Cardiac Birth Defects in an Avian Model of Maternal Phenylketonuria A THESIS SUBMITTED TO THE GRADUATE FACULTY In partial fulfillment of the requirements For the degree of MASTER OF SCIENCE IN BIOLOGY By Jamie N. Watson Edmond, OK June 5, 2018 J. Watson/Dr. Nikki Seagraves ii J. Watson/Dr. Nikki Seagraves Acknowledgements It is difficult to articulate the amount of gratitude I have for the support and encouragement I have received throughout my master’s thesis. Many people have added value and support to my life during this time. I am thankful for the education, experience, and friendships I have gained at the University of Central Oklahoma. First, I would like to thank Dr. Nikki Seagraves for her mentorship and friendship. I lucked out when I met her. I have enjoyed working on this project and I am very thankful for her support. I would like thank Thomas Crane for his support and patience throughout my master’s degree. I would like to thank Dr. Shannon Conley for her continued mentorship and support. I would like to thank Liz Bullen and Dr. Eric Howard for their training and help on this project. I would like to thank Kristy Meyer for her friendship and help throughout graduate school. I would like to thank my committee members Dr. Robert Brennan and Dr. Lilian Chooback for their advisement on this project. Also, I would like to thank the biology faculty and staff. I would like to thank the Seagraves lab members: Jailene Canales, Kayley Pate, Mckayla Muse, Grace Thetford, Kody Harvey, Jordan Guffey, and Kayle Patatanian for their hard work and support.
    [Show full text]
  • Wide-Scale Analysis of Human Functional Transcription Factor
    Wide-Scale Analysis of Human Functional Transcription Factor Binding Reveals a Strong Bias towards the Transcription Start Site Yuval Tabach1,2, Ran Brosh2, Yossi Buganim2, Anat Reiner1, Or Zuk1, Assif Yitzhaky1, Mark Koudritsky1, Varda Rotter2 and Eytan Domany1,* 1Departments of Physics of Complex Systems and 2Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel *Corresponding author. Email: [email protected] Tel: +972-8-9343964 Fax: +972-8- 9344109 Running title: Binding Sites Location Bias Keywords: Transcription factor binding sites, location bias, cell cycle, NF-kB, promoter, Gene Ontology, TATA, myocardin 1 Summary Background: Elucidating basic principles that underlie regulation of gene expression by transcription factors (TFs) is a central challenge of the post-genomic era. Transcription factors regulate expression by binding to specific DNA sequences; such a binding event is functional when it affects gene expression. Functionality of a binding site is reflected in conservation of the binding sequence during evolution and in over represented binding in gene groups with coherent biological functions. Functionality is governed by several parameters such as the TF- DNA binding strength, distance of the binding site from the transcription start site (TSS), DNA packing, and more. Understanding how these parameters control functionality of different TFs in different biological contexts is an essential step towards identifying functional TF binding sites, a must for understanding regulation of transcription. Methodology/Principal Findings: We introduce a novel method to screen the promoters of a set of genes with shared biological function, against a precompiled library of motifs, and find those motifs which are statistically over-represented in the gene set.
    [Show full text]
  • Supplementary Figure S4
    18DCIS 18IDC Supplementary FigureS4 22DCIS 22IDC C D B A E (0.77) (0.78) 16DCIS 14DCIS 28DCIS 16IDC 28IDC (0.43) (0.49) 0 ADAMTS12 (p.E1469K) 14IDC ERBB2, LASP1,CDK12( CCNE1 ( NUTM2B SDHC,FCGR2B,PBX1,TPR( CD1D, B4GALT3, BCL9, FLG,NUP21OL,TPM3,TDRD10,RIT1,LMNA,PRCC,NTRK1 0 ADAMTS16 (p.E67K) (0.67) (0.89) (0.54) 0 ARHGEF38 (p.P179Hfs*29) 0 ATG9B (p.P823S) (0.68) (1.0) ARID5B, CCDC6 CCNE1, TSHZ3,CEP89 CREB3L2,TRIM24 BRAF, EGFR (7p11); 0 ABRACL (p.R35H) 0 CATSPER1 (p.P152H) 0 ADAMTS18 (p.Y799C) 19q12 0 CCDC88C (p.X1371_splice) (0) 0 ADRA1A (p.P327L) (10q22.3) 0 CCNF (p.D637N) −4 −2 −4 −2 0 AKAP4 (p.G454A) 0 CDYL (p.Y353Lfs*5) −4 −2 Log2 Ratio Log2 Ratio −4 −2 Log2 Ratio Log2 Ratio 0 2 4 0 2 4 0 ARID2 (p.R1068H) 0 COL27A1 (p.G646E) 0 2 4 0 2 4 2 EDRF1 (p.E521K) 0 ARPP21 (p.P791L) ) 0 DDX11 (p.E78K) 2 GPR101, p.A174V 0 ARPP21 (p.P791T) 0 DMGDH (p.W606C) 5 ANP32B, p.G237S 16IDC (Ploidy:2.01) 16DCIS (Ploidy:2.02) 14IDC (Ploidy:2.01) 14DCIS (Ploidy:2.9) -3 -2 -1 -3 -2 -1 -3 -2 -1 -3 -2 -1 -3 -2 -1 -3 -2 -1 Log Ratio Log Ratio Log Ratio Log Ratio 12DCIS 0 ASPM (p.S222T) Log Ratio Log Ratio 0 FMN2 (p.G941A) 20 1 2 3 2 0 1 2 3 2 ERBB3 (p.D297Y) 2 0 1 2 3 20 1 2 3 0 ATRX (p.L1276I) 20 1 2 3 2 0 1 2 3 0 GALNT18 (p.F92L) 2 MAPK4, p.H147Y 0 GALNTL6 (p.E236K) 5 C11orf1, p.Y53C (10q21.2); 0 ATRX (p.R1401W) PIK3CA, p.H1047R 28IDC (Ploidy:2.0) 28DCIS (Ploidy:2.0) 22IDC (Ploidy:3.7) 22DCIS (Ploidy:4.1) 18IDC (Ploidy:3.9) 18DCIS (Ploidy:2.3) 17q12 0 HCFC1 (p.S2025C) 2 LCMT1 (p.S34A) 0 ATXN7L2 (p.X453_splice) SPEN, p.P677Lfs*13 CBFB 1 2 3 4 5 6 7 8 9 10 11
    [Show full text]
  • Co-Occupancy by Multiple Cardiac Transcription Factors Identifies
    Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart Aibin Hea,b,1, Sek Won Konga,b,c,1, Qing Maa,b, and William T. Pua,b,2 aDepartment of Cardiology and cChildren’s Hospital Informatics Program, Children’s Hospital Boston, Boston, MA 02115; and bHarvard Stem Cell Institute, Harvard University, Cambridge, MA 02138 Edited by Eric N. Olson, University of Texas Southwestern, Dallas, TX, and approved February 23, 2011 (received for review November 12, 2010) Identification of genomic regions that control tissue-specific gene study of a handful of model genes (e.g., refs. 7–10), it has not been expression is currently problematic. ChIP and high-throughput se- evaluated using unbiased, genome-wide approaches. quencing (ChIP-seq) of enhancer-associated proteins such as p300 In this study, we used a modified ChIP-seq approach to define identifies some but not all enhancers active in a tissue. Here we genome wide the binding sites of these cardiac TFs (1). We show that co-occupancy of a chromatin region by multiple tran- provide unbiased support for collaborative TF interactions in scription factors (TFs) identifies a distinct set of enhancers. GATA- driving cardiac gene expression and use this principle to show that chromatin co-occupancy by multiple TFs identifies enhancers binding protein 4 (GATA4), NK2 transcription factor-related, lo- with cardiac activity in vivo. The majority of these multiple TF- cus 5 (NKX2-5), T-box 5 (TBX5), serum response factor (SRF), and “ binding loci (MTL) enhancers were distinct from p300-bound myocyte-enhancer factor 2A (MEF2A), here referred to as cardiac enhancers in location and functional properties.
    [Show full text]
  • Myocardin (MYOCD) (NM 001146312) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC229055L3 Myocardin (MYOCD) (NM_001146312) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: Myocardin (MYOCD) (NM_001146312) Human Tagged ORF Clone Tag: Myc-DDK Symbol: MYOCD Synonyms: MGBL; MYCD Vector: pLenti-C-Myc-DDK-P2A-Puro (PS100092) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(RC229055). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_001146312 ORF Size: 2958 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 Myocardin (MYOCD) (NM_001146312) Human Tagged ORF Clone – RC229055L3 OTI Disclaimer: Due to the inherent nature of this plasmid, standard methods to replicate additional amounts of DNA in E. coli are highly likely to result in mutations and/or rearrangements. Therefore, OriGene does not guarantee the capability to replicate this plasmid DNA. Additional amounts of DNA can be purchased from OriGene with batch-specific, full-sequence verification at a reduced cost. Please contact our customer care team at [email protected] or by calling 301.340.3188 option 3 for pricing and delivery. The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g.
    [Show full text]
  • The Regulation of Lunatic Fringe During Somitogenesis
    THE REGULATION OF LUNATIC FRINGE DURING SOMITOGENESIS DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Emily T. Shifley ***** The Ohio State University 2009 Dissertation Committee: Approved by Professor Susan Cole, Advisor Professor Christine Beattie _________________________________ Professor Mark Seeger Advisor Graduate Program in Molecular Genetics Professor Michael Weinstein ABSTRACT Somitogenesis is the morphological hallmark of vertebrate segmentation. Somites bud from the presomitic mesoderm (PSM) in a sequential, periodic fashion and give rise to the rib cage, vertebrae, and dermis and muscles of the back. The regulation of somitogenesis is complex. In the posterior region of the PSM, a segmentation clock operates to organize cohorts of cells into presomites, while in the anterior region of the PSM the presomites are patterned into rostral and caudal compartments (R/C patterning). Both of these stages of somitogenesis are controlled, at least in part, by the Notch pathway and Lunatic fringe (Lfng), a glycosyltransferase that modifies the Notch receptor. To dissect the roles played by Lfng during somitogenesis, we created a novel allele that lacks cyclic Lfng expression within the segmentation clock, but that maintains expression during R/C somite patterning (Lfng∆FCE1). Lfng∆FCE1/∆FCE1 mice have severe defects in their anterior vertebrae and rib cages, but relatively normal sacral and tail vertebrae, unlike Lfng knockouts. Segmentation clock function is differentially affected by the ∆FCE1 deletion; during anterior somitogenesis the expression patterns of many clock genes are disrupted, while during posterior somitogenesis, certain clock components have recovered. R/C patterning occurs relatively normally in Lfng∆FCE1/∆FCE1 embryos, likely contributing to the partial phenotype rescue, and confirming that Lfng ii plays separate roles in the two regions of the PSM.
    [Show full text]
  • Gene Expression During Normal and FSHD Myogenesis Tsumagari Et Al
    Gene expression during normal and FSHD myogenesis Tsumagari et al. Tsumagari et al. BMC Medical Genomics 2011, 4:67 http://www.biomedcentral.com/1755-8794/4/67 (27 September 2011) Tsumagari et al. BMC Medical Genomics 2011, 4:67 http://www.biomedcentral.com/1755-8794/4/67 RESEARCHARTICLE Open Access Gene expression during normal and FSHD myogenesis Koji Tsumagari1, Shao-Chi Chang1, Michelle Lacey2,3, Carl Baribault2,3, Sridar V Chittur4, Janet Sowden5, Rabi Tawil5, Gregory E Crawford6 and Melanie Ehrlich1,3* Abstract Background: Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contraction of an array of tandem 3.3-kb repeats (D4Z4) at 4q35. Within each repeat unit is a gene, DUX4, that can encode a protein containing two homeodomains. A DUX4 transcript derived from the last repeat unit in a contracted array is associated with pathogenesis but it is unclear how. Methods: Using exon-based microarrays, the expression profiles of myogenic precursor cells were determined. Both undifferentiated myoblasts and myoblasts differentiated to myotubes derived from FSHD patients and controls were studied after immunocytochemical verification of the quality of the cultures. To further our understanding of FSHD and normal myogenesis, the expression profiles obtained were compared to those of 19 non-muscle cell types analyzed by identical methods. Results: Many of the ~17,000 examined genes were differentially expressed (> 2-fold, p < 0.01) in control myoblasts or myotubes vs. non-muscle cells (2185 and 3006, respectively) or in FSHD vs. control myoblasts or myotubes (295 and 797, respectively). Surprisingly, despite the morphologically normal differentiation of FSHD myoblasts to myotubes, most of the disease-related dysregulation was seen as dampening of normal myogenesis- specific expression changes, including in genes for muscle structure, mitochondrial function, stress responses, and signal transduction.
    [Show full text]
  • Modeling the Human Segmentation Clock with Pluripotent Stem Cells 2 3 Mitsuhiro Matsuda1,10, Yoshihiro Yamanaka2,10, Maya Uemura2,3, Mitsujiro Osawa4, 4 Megumu K
    bioRxiv preprint doi: https://doi.org/10.1101/562447; this version posted February 27, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Modeling the Human Segmentation Clock with Pluripotent Stem Cells 2 3 Mitsuhiro Matsuda1,10, Yoshihiro Yamanaka2,10, Maya Uemura2,3, Mitsujiro Osawa4, 4 Megumu K. Saito4, Ayako Nagahashi4, Megumi Nishio3, Long Guo5, Shiro Ikegawa5, 5 Satoko Sakurai6, Shunsuke Kihara7, Michiko Nakamura6, Tomoko Matsumoto6, Hiroyuki 6 Yoshitomi2,3, Makoto Ikeya6, Takuya Yamamoto6,8, Knut Woltjen6,9, Miki Ebisuya1*, 7 Junya Toguchida2,3, Cantas Alev2* 8 9 1 Laboratory for Reconstitutive Developmental Biology, RIKEN Center for Biosystems 10 Dynamics Research (RIKEN BDR), Kobe 650-0047, Japan. 11 2 Department of Cell Growth and Differentiation, Center for iPS Cell Research and 12 Application (CiRA), Kyoto University, Kyoto 606-8507, Japan. 13 3 Department of Regeneration Science and Engineering, Institute for Frontier Life and 14 Medical Sciences, Kyoto University, Kyoto 606-8507, Japan. 15 4 Department of Clinical Application, Center for iPS Cell Research and Application 16 (CiRA), Kyoto University, Kyoto 606-8507, Japan. 17 5 Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical 18 Sciences (RIKEN IMS), Tokyo 108-8639, Japan. 19 6 Department of Life Science Frontiers, Center for iPS Cell Research and Application 20 (CiRA), Kyoto University, 606-8507, Kyoto 108-8639, Japan. 21 7 Department of Fundamental Cell Technology, Center for iPS Cell Research and 22 Application (CiRA), Kyoto University, Kyoto 606-8507, Japan. 23 8 AMED-CREST, AMED 1-7-1 Otemachi, Chiyodaku, Tokyo 100-004, Japan.
    [Show full text]